Prosecution Insights
Last updated: October 01, 2026
Application No. 19/080,085

FLUORINE ATOM CONTAINING SILANE COMPOUND

Non-Final OA §112
Filed
Mar 14, 2025
Priority
Nov 08, 2022 — JP 2022-179021 +1 more
Examiner
DESAI, ANISH P
Art Unit
Tech Center
Assignee
Daikin Industries Ltd.
OA Round
1 (Non-Final)
45%
Grant Probability
Moderate
1-2
OA Rounds
2y 3m
Est. Remaining
52%
With Interview

Examiner Intelligence

Grants 45% of resolved cases
45%
Career Allowance Rate
332 granted / 733 resolved
-14.7% vs TC avg
Moderate +7% lift
Without
With
+6.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
34 currently pending
Career history
765
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
46.1%
+6.1% vs TC avg
§102
14.8%
-25.2% vs TC avg
§112
32.5%
-7.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 733 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Claim Objections Claims 2-8 are objected to because of the following informalities: As to claims 2-8, insert “the” after “wherein”. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. As to claim 1, subscripts α1 and α2 in formula (1) are not defined in the claim. Accordingly, claim is indefinite, because it is unclear what is meant by these subscripts. Further, as to claim 1, this claim at lines 27-29 on page 2 of the Claims sheet recite “the occurrence order of the respective repeating units enclosed in the parentheses…is not limited”. It is unclear what is meant by this recitation, because the meets and bounds of this recitation in view of the specification are unclear. Further, as to claim 1, at line 41 on page 2 of the Claims sheet, this claim recites “15 is an integer of 1 to 10”. It is unclear what is meant by this recitation given that the number 15 is not within the range of 1 to 10. Further, as to claim 1, at line 44 on page 2 of the Claims sheet, this claim recites “expecting for XA and XB are single bonds”. It is unclear what is meant by the recitation “expecting”. Furthermore, XA and XB are defined at the first instances in the same claim at line 15 (page 1 of the Claims sheet) and at line 30 (page 2 of the Claims sheet) respectively. Accordingly, it is unclear what is meant by the recitation “expecting for XA and XB are single bonds”. As to claim 2, this claim recites “the occurrence order of the respective repeating units enclosed in the parentheses…is not limited”. It is unclear what is meant by this recitation, because the meets and bounds of this recitation in view of the specification are unclear. As to claim 5, this claim at lines 2-3 recites the following: PNG media_image1.png 96 587 media_image1.png Greyscale It is unclear whether the XB further refers to one of the following XB recited in claim 1 or is a different XB. PNG media_image2.png 177 643 media_image2.png Greyscale Further, as to claim 5, given that the XB is positively required to be present and represented by the formula in claim 2, then it is unclear how the subscript “c1” can be 0. It is unclear whether c1 should be an integer of 1 to 30 instead of 0 to 30 in claim 2. Clarification is requested from the applicant. As to claim 8, this claim recites “15 is an integer of 1 to 10”. It is unclear what is meant by this recitation given that the number 15 is not within the range of 1 to 10. The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claim 6 is rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Claim 6 recites group XB, which fails to further limit, or fails to include all the limitations of parent claim 1 from which it depends on. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Inomata et al. (US 5118775) discloses a fluoroorganopolysiloxane and a process for preparing the same. Yamaguchi et al. (US 6221948 B1) disclose a carbon fluoride composition. Kitahara et al. (US 6303686 B1) discloses a resin composition having water and oil repellency. Yamaguchi et al. (US 6491979 B1) discloses a fluorine-containing surface treatment composition. Yamashita et al. (US 20200024241 A1) discloses a compound having isocyanuric skeleton. Nomura et al. (US 20220081590 A1) discloses stain-proof base material. Ikeuchi et al. (US 20220127418 A1) discloses fluoropolyether group containing silane compound. Nomura et al. (US 20220135839 A1) discloses surface treatment agent. Takano et al. (US 20250361250 A1) discloses fluorine containing silane compound. EP0558348 B2 discloses fluorine containing organosilicon compound. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANISH P DESAI whose telephone number is (571)272-6467. The examiner can normally be reached Mon-Fri 8:00 am ET to 4:30 PM ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Alicia Chevalier can be reached at 571-272-1490. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANISH P DESAI/ Primary Examiner, Art Unit 1788 September 4, 2026
Read full office action

Prosecution Timeline

Mar 14, 2025
Application Filed
Sep 09, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12747378
ADHESIVE COMPOSITION AND ADHESIVE SHEET
6y 7m to grant Granted Sep 29, 2026
Patent 12729325
ADHESIVE LABEL
2y 9m to grant Granted Sep 08, 2026
Patent 12692417
ADHESIVE TAPE
2y 10m to grant Granted Jul 28, 2026
Patent 12692419
PRESSURE-SENSITIVE ADHESIVE
2y 2m to grant Granted Jul 28, 2026
Patent 12686786
COATING COMPOSITION, ADHESIVE OR NON-ADHESIVE COATING LAYER CONTAINING SAID COATING COMPOSITION, AND LAMINATE INCLUDING THESE COATING LAYERS
2y 10m to grant Granted Jul 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
45%
Grant Probability
52%
With Interview (+6.9%)
3y 9m (~2y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 733 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month